{
  "author": {
    "name": "Anna Edney Jared S Hopkins Natasha Rausch",
    "webUrl": "/author/profile/anna-edney-jared-s-hopkins-natasha-rausch/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2017/11/15/new-hhs-director-blames-pbms-insurance-plans-for-h/",
        "title": "New HHS director blames PBMs, insurance plans for high drug prices",
        "byline": " Anna Edney, Jared S. Hopkins, Natasha Rausch ",
        "kicker": "",
        "prettyDate": "November 15, 2017",
        "timeToRead": "5 minute",
        "image": {
          "uri": "",
          "width": "",
          "height": ""
        },
        "authors": [
          {
            "webUrl": "/author/profile/anna-edney-jared-s-hopkins-natasha-rausch/",
            "name": "Anna Edney, Jared S. Hopkins, Natasha Rausch"
          }
        ],
        "kickerNode": [],
        "summary": "Alex Azar isnt likely to shy away from the topic of sky-high medication prices -- but it may be insurers and drug plans that feel the heat as much as his former industry.",
        "body": null
      }
    ]
  }
}